An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome
Clinical trial NCT01751867 · COMPLETED
Trial details
- NCT number
- NCT01751867
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-05-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.